Added to YB: 2025-07-08
Pitch date: 2025-07-04
HVO.L [bullish]
hVIVO plc
-36.19%
current return
Author Info
DeepValue Capital is investing in quality turnaround companies. Sign up for the newsletter.
Company Info
hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
Market Cap
GBP 47.7M
Pitch Price
GBP 0.10
Price Target
43.55 (+64900%)
Dividend
N/A
EV/EBITDA
35.49
P/E
-7.95
EV/Sales
0.97
Sector
Life Sciences Tools and Services
Category
value
hVIVO | The CRO Niche Leader Everyone’s Ignoring, and It’s a 4x Setup
HVO.L: Global leader in human challenge trials at ~70% off after guidance cut. £62.7M rev +12% YoY, 26.2% EBITDA margin. Controls 50%+ market share with proprietary viral strains and 170 beds. Two acquisitions expand capabilities. £44M cash, no dilution. 2028 target: £100M rev, £20M FCF. Risks: customer concentration, biotech funding. PT 43.55p (306% upside).
Read full article (7 min)